Rouhbakhsh Talks About Being a Trusted Voice on COVID-19
Rambod A. Rouhbakhsh, MD, principal investigator for Hattiesburg Clinic MediSync® Clinical Research, recently spoke with the American Medical Association about his work with the clinic and how he became a trusted, local voice on COVID-19.
Dr. Rouhbakhsh diagnosed the first case of COVID-19 in Mississippi, back in March 2020. The clinic quickly rallied with Forrest General Hospital to establish the Cough & Fever Clinic. Around this time, Dr. Rouhbakhsh agreed to do a regular spot with a local media affiliate, WDAM. He said, “Yes.”
“Dr. Rouhbakhsh has been an exceptional resource for Hattiesburg Clinic, our patients and community in the face of the COVID-19 pandemic,” Kristy Gould, director of Corporate Planning & Development said. “He quickly rose to the occasion, serving as a reputable medical source in the media for countless individuals as we all sought day-to-day answers about the virus. Not only has his insight been used locally, he has been quoted through publications like the American Medical Association and Kaiser Permanente News.”
In his capacity with MediSync, he supervised the local trials for the Moderna vaccine. This gave Hattiesburg Clinic the opportunity to share first-hand knowledge of the trial as well as insight to some of the struggles of understanding a new virus.
Follow the link to read the full article: https://bit.ly/3bASkz1